Pathology & Oncology Research

, Volume 21, Issue 2, pp 433–437 | Cite as

Genetic Polymorphism of CAT C-262 T and Susceptibility to Breast Cancer, a Case–Control Study and Meta-Analysis of the Literatures

  • Mostafa SaadatEmail author
  • Shekoofeh Saadat


Catalase (CAT) activity is likely to be affected by functional polymorphism of C-262 T (rs1001179) in the CAT gene (OMIM: 115500). It is hypothesized that individuals with the lower expressing forms of the CAT polymorphism may be more susceptible to breast cancer. Therefore, the present case–control study and meta-analysis were carried out. The present case–control study consisted of 407 females with breast cancer and a total of 395 healthy female from population matched with patients according to age. Genotypic analysis for the CAT C-262 T polymorphism was determined by PCR. We identified 7 eligible studies, including 10,471 subjects (4,959 patients, and 5,512 healthy controls) in relation to the CAT C-262 T polymorphism and breast cancer risk. Based on the present case–control study, the CT (OR = 0.90, 95 % CI: 0.66–1.22, P = 0.484) and TT (OR = 0.68, 95 % CI: 0.35–1.30, P = 0.245) genotypes were not associated with breast cancer risk compared to the CC genotype. For meta-analysis including all studies, there was significant heterogeneity between studies. The overall ORs of the breast cancer risk were not associated with the CT (Q-statistic = 14.90, df = 6, P < 0.05; OR = 1.01, 95 % CI: 0.92–1.09, P = 0.862) and TT (Q-statistic = 2.57, df = 6, P > 0.05; OR = 1.03, 95 % CI: 0.85–1.24, P = 0.770) genotypes. There was no association between C-262 T polymorphism of the CAT and risk of breast cancer.


Breast cancer CAT Genetic polymorphism Meta-analysis 



The authors are indebted to the participants for their close cooperation. The authors are indebted to Dr. Maryam Ansari-Lari for critical reading of the manuscript and for her contribution in discussion. This study was supported by Shiraz University.

Conflict of Interest

No competing interests are declared by any of the authors.


  1. 1.
    Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267CrossRefPubMedGoogle Scholar
  2. 2.
    Kang DH (2002) Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 13:540–549CrossRefPubMedGoogle Scholar
  3. 3.
    Ambrosone CB (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2:903–917CrossRefPubMedGoogle Scholar
  4. 4.
    Emerit I (1994) Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med 16:99–109CrossRefPubMedGoogle Scholar
  5. 5.
    Loft S, Olsen A, Møller P, Poulsen HE, Tjønneland A (2013) Association between 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion and risk of postmenopausal breast cancer: nested case–control study. Cancer Epidemiol Biomarkers Prev 22:1289–1296CrossRefPubMedGoogle Scholar
  6. 6.
    Chang D, Wang F, Zhao YS, Pan HZ (2008) Evaluation of oxygen stress in colorectal cancer patients. Biomed Environ Sci 21:286–289CrossRefPubMedGoogle Scholar
  7. 7.
    Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, Kadlubar FF, Ratnasinghe LD, Ambrosone CB (2006) Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 15:1217–1222CrossRefPubMedGoogle Scholar
  8. 8.
    Nadif R, Mintz M, Jedlicka A, Bertrand JP, Kleeberger SR, Kauffmann F (2005) Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 39:1345–1350CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Nowell S, Davis W, Garza C, Neugut AI, Ambrosone CB (2005) Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 162:943–952CrossRefPubMedGoogle Scholar
  10. 10.
    Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA (2006) Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Res 66:1225–1233CrossRefPubMedGoogle Scholar
  11. 11.
    Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL (2008) Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17:1082–1087CrossRefPubMedGoogle Scholar
  12. 12.
    Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun MJ, Hong CC (2009) Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinog 30:777–784CrossRefGoogle Scholar
  13. 13.
    Tsai S, Wu S, Hou M, Chen Y, Ma H, Tsai L (2012) Oxidative stress-related enzyme gene polymorphisms and susceptibility to breast cancer in non-smoking, non-alcohol consuming Taiwanese women: a case–control study. Ann Clin Biochem 49:152–158CrossRefPubMedGoogle Scholar
  14. 14.
    McCullough LE, Santella RM, Cleveland RJ, Bradshaw PT, Millikan RC, North KE, Olshan AF, Eng SM, Ambrosone CB, Ahn J, Steck SE, Teitelbaum SL, Neugut AI, Gammon MD (2012) Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk. Cancer Causes Control 23:1949–1958CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Abu-Amero KK, Azad TA, Mousa A, Osman EA, Sultan T, Al-Obeidan SA (2013) A catalase promoter variant rs1001179 is associated with visual acuity but not with primary angle closure glaucoma in Saudi patients. BMC Med Genet 14:84CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Babusikova E, Jesenak M, Evinova A, Banovcin P, Dobrota D (2013) Frequency of polymorphism -262 C/T in catalase gene and oxidative damage in Slovak children with bronchial asthma. Arch Bronconeumol 49:507–512CrossRefPubMedGoogle Scholar
  17. 17.
    Tefik T, Kucukgergin C, Sanli O, Oktar T, Seckin S, Ozsoy C (2013) Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease. BJU Int 112:E406–E414CrossRefPubMedGoogle Scholar
  18. 18.
    Khodayari S, Salehi Z, Fakhrieh Asl S, Aminian K, Mirzaei-Gisomi N, Torabi-Dalivandan S (2013) Catalase gene C-262T polymorphism: importance in ulcerative colitis. J Gastroenterol Hepatol 28:819–822CrossRefPubMedGoogle Scholar
  19. 19.
    Karunasinghe N, Han DY, Goudie M, Zhu S, Bishop K, Wang A, Duan H, Lange K, Ko S, Medhora R, Kan ST, Masters J, Ferguson LR (2012) Prostate disease risk factors among a New Zealand cohort. J Nutrigenet Nutrigenomics 5:339–351CrossRefPubMedGoogle Scholar
  20. 20.
    Komina AV, Korostileva KA, Gyrylova SN, Belonogov RN, Ruksha TG (2012) Interaction between single nucleotide polymorphism in catalase gene and catalase activity under the conditions of oxidative stress. Physiol Res 61:655–658PubMedGoogle Scholar
  21. 21.
    Chang D, Hu ZL, Zhang L, Zhao YS, Meng QH, Guan QB, Zhou J, Pan HZ (2012) Association of catalase genotype with oxidative stress in the predication of colorectal cancer: modification by epidemiological factors. Biomed Environ Sci 25:156–162PubMedGoogle Scholar
  22. 22.
    Ghaly MS, Ghattas MH, Labib SM (2012) Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt. Lupus 21:1244–1249CrossRefPubMedGoogle Scholar
  23. 23.
    Góth L, Nagy T, Kósa Z, Fejes Z, Bhattoa HP, Paragh G, Káplár M (2012) Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus. Free Radic Res 46:1249–1257CrossRefPubMedGoogle Scholar
  24. 24.
    Dutkiewicz G, Domanski L, Binczak-Kuleta A, Pawlik A, Safranow K, Ciechanowicz A, Dziedziejko V, Ciechanowski K (2010) The association of -262C/T polymorphism in the catalase gene and delayed graft function of kidney allografts. Nephrol (Carlton) 15:587–591CrossRefGoogle Scholar
  25. 25.
    Mohamadynejad P, Saadat M (2008) Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran). Mol Biol Rep 35:669–672CrossRefPubMedGoogle Scholar
  26. 26.
    Rafiee L, Saadat I, Saadat M (2010) Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 37:155–158CrossRefPubMedGoogle Scholar
  27. 27.
    Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C (2007) Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem 53:1734–1740CrossRefPubMedGoogle Scholar
  28. 28.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMedGoogle Scholar
  29. 29.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  30. 30.
    Chang D, Hu ZL, Zhang L, Zhao YS, Meng QH, Guan QB, Zhou J, Pan HZ (2012) Association of catalase genotype with oxidative stress in the prediction of colorectal cancer: Modification by epidemiological factors. Biomed Environ Sci 25:156–162PubMedGoogle Scholar
  31. 31.
    Komina AV, Korostileva KA, Gyrylova SN, Benlonogov RN, Ruksha TG (2012) Interaction between single nucleotide polymorphism in catalase gene and catalase acticity under the conditions of oxidative etress. Physiol Res 61:655–658PubMedGoogle Scholar
  32. 32.
    Saadat M (2006) Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 97:505–509CrossRefPubMedGoogle Scholar
  33. 33.
    Kiyohara C, Takayama K, Nakanishi Y (2006) Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54:267–283CrossRefPubMedGoogle Scholar
  34. 34.
    Saadat M, Ansari-Lari M (2007) Genetic polymorphism of glutathione S-transferase T1, M1 and asthma, a meta-analysis of the literature. Pak J Biol Sci 10:4183–4189CrossRefPubMedGoogle Scholar
  35. 35.
    Saadat M, Ansari-Lari M (2009) Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 115:137–144CrossRefPubMedGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2014

Authors and Affiliations

  1. 1.Department of Biology, College of SciencesShiraz UniversityShirazIran
  2. 2.Institute of BiotechnologyShiraz UniversityShirazIran

Personalised recommendations